ArticleAnnals of hematology2025

Interstitial lung disease presents with varying characteristics in patients with non-Hodgkin lymphoma undergoing rituximab-containing therapies.

Wailong Zou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.